Among them, the COL6A5+ COL18A1+ fibroblast subsets expressing inflammatory factors (CCL2, CCL19, CCL26, and IL-32) are unique to AD patients and are concentrated mainly at the dermal-epidermal junction. This evidence concerns the gene COL18A1 and Alzheimer disease.